{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:56:34Z","timestamp":1780775794082,"version":"3.54.1"},"reference-count":37,"publisher":"Baskent University","issue":"Suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.6002\/ect.pediatricsymp2022.o34","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T07:43:12Z","timestamp":1652686992000},"page":"105-111","source":"Crossref","is-referenced-by-count":6,"title":["BK Polyomavirus Infection and Risk Factors in Pediatric Patients Undergoing Kidney Transplant"],"prefix":"10.6002","volume":"20","author":[{"given":"Beg\u00fcm","family":"Avc\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Bask\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaan","family":"G\u00fcllero\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"Ecevit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Ayvazo\u011flu Soy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"Moray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Haberal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"key":"ref0","unstructured":"References"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"1. Ahlenstiel-Grunow T, Pape L. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation. Pediatr Nephrol. 2020;35(3):375-382. doi:10.1007\/s00467-018-4164-3","DOI":"10.1007\/s00467-018-4164-3"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"2. Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation. 2009;87(5):621-630. doi:10.1097\/TP.0b013e318197c17d","DOI":"10.1097\/TP.0b013e318197c17d"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"3. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199(6):837-846. doi:10.1086\/597126","DOI":"10.1086\/597126"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"4. Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol. 2007;2(5):1037-1042. doi:10.2215\/CJN.04051206","DOI":"10.2215\/CJN.04051206"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"5. Kayler L, Zendejas I, Schain D, Magliocca J. Ureteral stent placement and BK viremia in kidney transplant recipients. Transpl Infect Dis. 2013;15(2):202-207. doi:10.1111\/tid.12051","DOI":"10.1111\/tid.12051"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"6. Demey B, Tinez C, Francois C, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review. J Clin Virol. 2018;109:6-12. doi:10.1016\/j.jcv.2018.10.002","DOI":"10.1016\/j.jcv.2018.10.002"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"7. Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009;87(7):1019-1026. doi:10.1097\/TP.0b013e31819cc383","DOI":"10.1097\/TP.0b013e31819cc383"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"8. Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009;22(6):626-634. doi:10.1111\/j.1432-2277.2009.00842.x","DOI":"10.1111\/j.1432-2277.2009.00842.x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"9. Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77(4):299-311. doi:10.1038\/ki.2009.377","DOI":"10.1038\/ki.2009.377"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"10. Zarauza Santovena A, Garcia Meseguer C, Martinez Mejia S, et al. BK virus infection in pediatric renal transplantation. Transplant Proc. 2015;47(1):62-66. doi:10.1016\/j.transproceed.2014.11.020","DOI":"10.1016\/j.transproceed.2014.11.020"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"11. Hocker B, Schneble L, Murer L, et al. Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN registry study. Transplantation. 2019;103(6):1224-1233. doi:10.1097\/TP.0000000000002414","DOI":"10.1097\/TP.0000000000002414"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"12. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5(3):582-594. doi:10.1111\/j.1600-6143.2005.00742.x","DOI":"10.1111\/j.1600-6143.2005.00742.x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"13. Kwon Y, Kim JY, Lee Y, Cho H. Clinical manifestations of BK virus infection in pediatric kidney transplant patients. Korean J Pediatr. 2019;62(11):422-427. doi:10.3345\/kjp.2019.00388","DOI":"10.3345\/kjp.2019.00388"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"14. Sharma R, Zachariah M. BK virus nephropathy: prevalence, impact and management strategies. Int J Nephrol Renovasc Dis. 2020;13:187-192. doi:10.2147\/IJNRD.S236556","DOI":"10.2147\/IJNRD.S236556"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"15. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant. 2007;7(12):2727-2735. doi:10.1111\/j.1600-6143.2007.01984.x","DOI":"10.1111\/j.1600-6143.2007.01984.x"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"16. Hymes LC, Warshaw BL. Polyomavirus (BK) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant. 2006;10(8):920-922. doi:10.1111\/j.1399-3046.2006.00575.x","DOI":"10.1111\/j.1399-3046.2006.00575.x"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"17. Geddes CC, Gunson R, Mazonakis E, et al. BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen. Transpl Infect Dis. 2011;13(2):109-116. doi:10.1111\/j.1399-3062.2010.00566.x","DOI":"10.1111\/j.1399-3062.2010.00566.x"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"18. Almeras C, Vetromile F, Garrigue V, Szwarc I, Foulongne V, Mourad G. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients. Transpl Infect Dis. 2011;13(2):101-108. doi:10.1111\/j.1399-3062.2011.00619.x","DOI":"10.1111\/j.1399-3062.2011.00619.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"19. Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. Transplantation. 2012;94(8):814-821. doi:10.1097\/TP.0b013e31826690c6","DOI":"10.1097\/TP.0b013e31826690c6"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"20. Favi E, Puliatti C, Sivaprakasam R, et al. Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation. World J Clin Cases. 2019;7(3):270-290. doi:10.12998\/wjcc.v7.i3.270","DOI":"10.12998\/wjcc.v7.i3.270"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"21. Viscount HB, Eid AJ, Espy MJ, et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation. 2007;84(3):340-345. doi:10.1097\/01.tp.0000275205.41078.51","DOI":"10.1097\/01.tp.0000275205.41078.51"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"22. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79(10):1277-1286. doi:10.1097\/01.tp.0000156165.83160.09","DOI":"10.1097\/01.TP.0000156165.83160.09"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"23. Hirsch HH, Babel N, Comoli P, et al. European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clin Microbiol Infect. 2014;20 Suppl 7:74-88. doi:10.1111\/1469-0691.12538","DOI":"10.1111\/1469-0691.12538"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"24. El Ansary M, Abd Elhamid S, Saadi G, et al. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients. Transpl Infect Dis. 2016;18(4):529-537. doi:10.1111\/tid.12557","DOI":"10.1111\/tid.12557"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"25. Saleh A, El Din Khedr MS, Ezzat A, Takou A, Halawa A. Update on the management of BK virus infection. Exp Clin Transplant. 2020;18(6):659-670. doi:10.6002\/ect.2019.0254","DOI":"10.6002\/ect.2019.0254"},{"key":"ref26","unstructured":"26. Kong XR, Li XB, Sun YJ, Zhang TY, Xiao L, Shi BY. [Analysis of BK virus infection in kidney transplant recipients]. Zhonghua Yi Xue Za Zhi. 2020;100(48):3859-3862. doi:10.3760\/cma.j.cn112137-20200817-02404"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"27. Maliakkal JG, Brennan DC, Goss C, et al. Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation. Transpl Int. 2017;30(2):153-161. doi:10.1111\/tri.12888","DOI":"10.1111\/tri.12888"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"28. Wingate JT, Brandenberger J, Weiss A, Scovel LG, Kuhr CS. Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation. Transpl Infect Dis. 2017;19(1). doi:10.1111\/tid.12644","DOI":"10.1111\/tid.12644"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"29. Hassig A, Roos M, Etter A, et al. Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor. Transpl Infect Dis. 2014;16(1):44-54. doi:10.1111\/tid.12153","DOI":"10.1111\/tid.12153"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"30. Wunderink HF, van der Meijden E, van der Blij-de Brouwer CS, et al. Pretransplantation donor-recipient pair seroreactivity against BK polyomavirus predicts viremia and nephropathy after kidney transplantation. Am J Transplant. 2017;17(1):161-172. doi:10.1111\/ajt.13880","DOI":"10.1111\/ajt.13880"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"31. Moura EB, Petzhold SV, Amaral AR, Deboni LM, Franca PHC. Evaluation of the predisposition and clinical impact of BK virus replication in kidney transplant patients. An Acad Bras Cienc. 2017;89(1 Suppl 0):675-684. doi:10.1590\/0001-3765201720160470","DOI":"10.1590\/0001-3765201720160470"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"32. Huang G, Zhang L, Liang X, et al. Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction. Transplant Proc. 2014;46(10):3448-3454. doi:10.1016\/j.transproceed.2014.08.036","DOI":"10.1016\/j.transproceed.2014.08.036"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"33. Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013;13(1):136-145. doi:10.1111\/j.1600-6143.2012.04320.x","DOI":"10.1111\/j.1600-6143.2012.04320.x"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"34. Theodoropoulos N, Wang E, Penugonda S, et al. BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation. Am J Transplant. 2013;13(1):197-206. doi:10.1111\/j.1600-6143.2012.04314.x","DOI":"10.1111\/j.1600-6143.2012.04314.x"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"35. Esmaili H, Mostafidi E, Ardalan M, Vahedi A, Mahmoodpoor F, Mohajel-Shoja M. BK virus nephropathy is not always alone. J Renal Inj Prev. 2016;5(1):12-16. doi:10.15171\/jrip.2016.03","DOI":"10.15171\/jrip.2016.03"},{"key":"ref36","unstructured":""}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T08:13:37Z","timestamp":1652688817000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/supplement\/2022\/20\/5\/3\/105\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":37,"journal-issue":{"issue":"Suppl 3","published-print":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.pediatricsymp2022.o34","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}